$TSEM's Path to $400+/Share

Tower Semiconductor $TSEM is at a major inflection point. The recent Japan announcement secures the foundation for rapid growth to support the scaling of CPO. Tower is taking 100% ownership of the 300mm Uozu fab (Fab 7), set to close early 2027. They are also purchasing adjacent land to 4x the 300mm footprint. This move eliminates joint-venture friction and gives Tower full control over its most advanced capacity.

The primary reward for shareholders is the silicon photonics (SiPho) expansion. Management originally targeted a 3x increase. They have now identified a path to 5x capacity by late 2026. This requires a $920m total investment. Over 70% of this capacity is already reserved through customer prepayments. This provides immense revenue visibility through 2028.

High-value 1.6T and 3.2T co-packaged optics (CPO) modules drive this demand. These advanced specialty processes command superior pricing power. Tower maintains an 85% market share in this niche.

My model assumes 30% of capacity remains uncontracted to capture spot market premiums from hyperscalers. Accounting for the 5x expansion and higher ASPs for 1.6T transceivers, we could see FY 2028 look like:

Revenue: $4.10 billion

Net Margin: 32.5%

Net Profit: $1.33 billion

When applying historical hypergrowth multiples from $TSM TSMC, leading foundries typically trade at 30x to 45x earnings during these capacity-constrained hyper growth cycles.

Base Case (30x P/E): $1.33B x 30 = $39.9B MC ($355/share)

Premium Multiple (40x P/E): $1.33B x 40 = $53.2B MC ($473/share)

The current price of ~$190 is still pricing in the earnings inflection to come in 2027-2028. The Japan expansion provides a growth track that extends well beyond 2028. Expect to continue to see $TSEM re-rate throughout 2026 as they hit key milestones and these estimates de-risk.